The pharmaceutical industry is anticipated to register a CAGR of 11.34 per cent until 2028. The sector has undergone a significant transformation owing to the emergence of new technologies, & more efficient manufacturing approaches.
Natco Pharma said it has submitted a new application with the US health regulator for marketing authorisation of the generic version of Olaparib tablets, used in treating certain forms of ovarian, breast, pancreatic and prostate cancers...
The All India Organization of Chemists & Druggists (AIOCD) has made a representation to the National Pharmaceutical Pricing Authority (NPPA) to streamline Trade Margin Rationalization (TMR) in view of the increase in Wholesale Price Index (WPI)...
Dr Reddy’s Laboratories (DRL), a Rs 21,500 crore plus pharma giant, has registered strong growth in consolidated net profit during the third quarter ended December 2022 on account of new product launches, higher volumes of base business and forex...
Meenakshi Nevatia has been appointed by Pfizer Limited as the company's managing director and additional director for a term of five years beginning on April 3, 2023. S.Sridhar, who announced his early retirement in August 2022, is succeeded by...
AstraZeneca, a British pharmaceutical firm, reported a record annual net profit, boosted by cancer treatments and the integration of biotech unit Alexion following a blockbuster takeover...
Wellmarker Bio Co., Ltd (WMBIO), a predictive biomarker-driven biotech company, has entered a clinical trial collaboration and supply agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA)....
With MagicPrep NGS and the AVITI System, Tecan and Element Biosciences, Inc, the developer of an innovative DNA sequencing platform that is disrupting genomics, are collaborating to offer a true benchtop NGS workflow. The collaboration will...
GlaxoSmithKline Pharmaceuticals Ltd, the Indian unit of UK's GSK plc, reported a 9.5 per cent rise in third-quarter profit, in line with analysts' estimates, as a sharp drop in input costs more than offset a revenue decline.
Actinium Pharmaceuticals, Inc., a pioneer in the development of targeted radiotherapies, announced a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), a component of the National Institutes of Health...
, CDSCO.jpg)
